Iran begins phase 2 and 3 of clinical trial of its first COVID-19 vaccine, COVIran Barekat with two lecturers of Tehran University volunteered to receive the vaccine.
Clinical trial for Iran’s corornavirus vaccine COVIran Barekat begins (photo)
16 Mar 2021 - 11:08
Iran begins phase 2 and 3 of clinical trial of its first COVID-19 vaccine, COVIran Barekat with two lecturers of Tehran University volunteered to receive the vaccine.
Story Code: 496639